@SjsmithStuart
Joined March 2015
Stuart Smith retweeted
Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows. Find out more in The Lancet: spkl.io/60137TUFS #EANO2026
7
54
2
146
28,998
Stuart Smith retweeted
🇬🇧 A “revolutionary” new procedure at London’s St Thomas’ Hospital can identify the cause of an infection with a single test, potentially within hours instead of days. Using an Oxford Nanopore GridION, it sequences genetic material in a patient sample and searches simultaneously for bacteria, viruses and fungi. For critically ill patients, that could mean finding the infection and choosing the right treatment far faster, while reducing unnecessary use of broad-spectrum antibiotics. It's not yet clear when the test could be made widely available, but it's the first step of a massive shift in the efficiency of diagnosing health issues everywhere. Writer: Mhedi
20
41
8
163
99,280
Stuart Smith retweeted
Correspondence: Clinical Long-Read Genome Sequencing for Rare-Disease Diagnostics nej.md/4e03ejh #Genetics
26
111
24,851
Stuart Smith retweeted
In a trial involving children with Chiari type I malformation and syringomyelia, the percentage with surgical complications did not differ significantly between posterior fossa decompression with duraplasty and decompression alone. Full trial results and Research Summary: nej.md/3RtZTQR
8
34
6,675
Stuart Smith retweeted
Correspondence: Toward Same-Day Genome Sequencing in the Critical Care Setting nej.md/4qg4KlE #ASHG25 | @GeneticsSociety
1
5
46
15,143
Stuart Smith retweeted
Traditional brain tumour characterisation requires a battery of tests, delaying critical treatment decisions. Discover how Oxford Nanopore sequencing streamlines this with a single, rapid assay to provide high-confidence tumour methylation profiling. nanoporetech.com/application…
2
6
1,094
Stuart Smith retweeted
Our winner of the Young Investigator Award 2025 is Phoebe McCrorie. Congratulations! Thank you to Karen Noble at Brain Tumour Research for supporting this alongside BNOS. Photo - Karen Noble, Phoebe McCrorie, Susan Short. #BNOS2025
2
6
593
A breakthrough moment in brain infections. Faced with a mystery infection, Judith Breuer sequenced a biopsy sample—and identified a pathogen never before linked to brain infections. Find out more. #NanoporeConf
1
4
1
5
1,537
Why wait weeks for a diagnosis? Danny Miller discusses the future potential of Oxford Nanopore sequencing, and how clinicians could get actionable results within hours—not days or weeks. No need to batch samples. Same-day sequencing, same-day answers. #NanoporeConf
2
4
5
1,238
In the studio, Matt Loose shares how: “Surgeons were literally knocking, saying I’ve got a patient today. Once people see what’s possible, they start to believe it — and get excited.” when talking about his new CNS tumour profiling method.
4
14
1,399
Knowledge is power. In the studio, Matt Loose shared insights on rapid CNS profiling — and how one participant told him: “Even if the answer isn’t what you want, it’s better than not knowing at all.”
1
5
12
1,719
Stuart Smith retweeted
Real time rapid prediction of acute leukemia via methylation profiles with @nanopore using #Marlin @DanaFarber #LondonCalling2025
2
1
11
2,021
Great news about a new test that reduces diagnosis time for certain types of brain tumour. This highlights the importance of continued research to improve earlier diagnosis and faster detection for the less survivable cancers. bbc.co.uk/news/articles/cpvk…
1
6
176
An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove uncertainty those face waiting weeks for their diagnosis and prognosis. Read more:bit.ly/43EbUXh
15
40
1,713
Groundbreaking research from scientists @mattloose from @UoNLifeSci @UoNFacultyMHS & Medics @NUHMedicine means brain tumours could be diagnosed in as little as 2 hours using technology from @nanopore Read the full story ▶️ ow.ly/h2vc50VW7mL
7
2
14
3,324
The future is now. In this webinar, Prof. Matt Loose showcases a revolutionary tool, ROBIN, that uses Oxford Nanopore technology for rapid and comprehensive molecular profiling of central nervous system tumours. Watch the webinar here: bit.ly/3REqZSd
5
3
1,310
From weeks to hours. Prof. Matt Loose shares a transformative tool (ROBIN) that uses Oxford Nanopore technology to rapidly and comprehensively classify central nervous system tumours in this webinar. Watch here to discover what’s possible: bit.ly/42FRV9g
4
1
11
1,426
Stuart Smith retweeted
Proud to support #ShineALight for Brain Tumour Awareness Month & ⁦@braintumourrsch⁩ - one in three of us know someone with a brain tumour (I lost a great mate, Miles, to glioblastoma recently) yet only 1% of the UK’s cancer research spend goes into them. This must change.
175
177
19
2,942
293,011
Stuart Smith retweeted
Congrats to @SjsmithStuart and Dr Simon Paine for winning the #NIHAwards Innovation award for work on bringing @nanopore sequencing into the clinic for rapid brain tumour diagnosis.
2
5
1
32
2,405
Sadly a similar experience already occurs for many brain tumour patients. Radical change needed as the number of patients across all cancers needing these tests increases rapidly
2
4
447